Evidence map›Paper›PMID 31848442›Full record

ArticleScientific reports2019

One-Pot Radiosynthesis and Biological Evaluation of a Caspase-3 Selective 5-[

Matthias Glaser, Vineeth Rajkumar, Seckou Diocou, Thibault Gendron, Ran Yan, Pak Kwan Brian Sin, Kerstin Sander, Laurence Carroll, R Barbara Pedley, Eric O Aboagye and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Radionuclide imaging of apoptosis for clinical application.European journal of nuclear medicine and molecular imaging · 2022
    Review
  6. Molecular Imaging of Apoptosis: The Case of Caspase-3 Radiotracers.International journal of molecular sciences · 2021
    Review
  7. [Cancers · 2020
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Matthias GlaserCentre for Radiopharmaceutical Chemistry, University College London, 5 Gower Place, London, WC1E 6BS, United Kingdom.
Vineeth RajkumarUCL, Cancer Institute, 72 Huntley Street, London, WC1E 6DD, UK.
Seckou DiocouUCL, Cancer Institute, 72 Huntley Street, London, WC1E 6DD, UK.
Thibault GendronCentre for Radiopharmaceutical Chemistry, University College London, 5 Gower Place, London, WC1E 6BS, United Kingdom.ORCID http://orcid.org/0000-0002-2162-3704
Ran YanKing's College London, School of Biomedical Engineering and Imaging Sciences, St. Thomas' Hospital, SE1 7EH, London, United Kingdom.
Pak Kwan Brian SinCentre for Radiopharmaceutical Chemistry, University College London, 5 Gower Place, London, WC1E 6BS, United Kingdom.
Kerstin SanderCentre for Radiopharmaceutical Chemistry, University College London, 5 Gower Place, London, WC1E 6BS, United Kingdom.
Laurence CarrollImperial College London, Science, Technology & Medicine, Department of Medicine, Hammersmith Hospital, DuCane Road, London, W12 0NN, United Kingdom.
R Barbara PedleyUCL, Cancer Institute, 72 Huntley Street, London, WC1E 6DD, UK.
Eric O AboagyeImperial College London, Science, Technology & Medicine, Department of Medicine, Hammersmith Hospital, DuCane Road, London, W12 0NN, United Kingdom.
Timothy H WitneyKing's College London, School of Biomedical Engineering and Imaging Sciences, St. Thomas' Hospital, SE1 7EH, London, United Kingdom.
Erik ÅrstadCentre for Radiopharmaceutical Chemistry, University College London, 5 Gower Place, London, WC1E 6BS, United Kingdom. e.arstad@ucl.ac.uk.ORCID http://orcid.org/0000-0002-3240-2106
University College London · GBCRUK Lung Cancer Centre of Excellence · GBHammersmith Hospital · GBSt Thomas' Hospital · GB

Funding

Cancer Research UK 10337Cancer Research UK 16463Cancer Research UK 21030Cancer Research UK C1519/A16463Cancer Research UK C2536/A10337Department of HealthMedical Research Council G1001497Medical Research Council MR/N020782/1
6 · The paper itself

Abstract

Induction of apoptosis is often necessary for successful cancer therapy, and the non-invasive monitoring of apoptosis post-therapy could assist in clinical decision making. Isatins are a class of compounds that target activated caspase-3 during apoptosis. Here we report the synthesis of the 5-iodo-1,2,3-triazole (FITI) analog of the PET tracer [

Indexed as

AnimalsApoptosisCaspase 3Cell Line, TumorCopperFluorine RadioisotopesHeterograftsHumansIodine RadioisotopesIsatinMiceNeoplasmsRadiopharmaceuticalsTissue DistributionTomography, Emission-Computed, Single-PhotonTriazolesCaspase 3CopperFluorine RadioisotopesIodine RadioisotopesIsatinRadiopharmaceuticalsTriazoles

Identifiers

PMID31848442
PMCPMC6917698
OpenAlexW2994708729

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.